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Institute, Moscow, Russia; 2Russian State Medical University, Moscow, Russia
Decreased bone mineral density (BMD) is a serious problem for clinicians who
care for adult CF patients.
The aim of our study was to determine the prevalence of decreased BMD in adults
with CF, and to assess risk factors for reduced bone mass in this group of patients.
Patients and methods. 56 patients (23 males, mean age 22.2+4.3 yrs) were included
in the study. BMD (expressed as a Z score) of L2−L4 spine and proximal femur were
measured with Dual-Energy X-ray Absorbtionmetry (DEXA) scans on Hologic-
4500A. Patients were divided into 3 groups: Z>−1 normal BMD, −1>Z>−2
ostiopenia, Z<−2 osteoporosis. Correlations between BMD and age, sex, anthropo-
metric data, the age of pulmonary and intestinal manifestations setup, glucocorticoid
use, physical activity, lung function, delF508 mutation, SatO2, dyspnea severety
(MRC scale).
Results: BMD was reduced in a total of 75% (n = 42) patients. Osteopenia was
diagnosed in 35.7% (n = 20), osteoporosis − in 39% (n = 22). Reduced bone density
signiﬁcantly correlated with FEV1 (p = 0.02), FVC (p = 0.03), SatO2 (p = 0.01),
physical activity (p = 0.01), dyspnea severity (p = 0.02).
Conclusion: Bone demineralization affects the majority of adult CF patients and is
strongly related to pulmonary disease severity. The basic CF care program should
include bone metabolism therapy.
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Background: Due to the improvement in life expectancy in CF, co-morbidities such
as diabetes and renal function impairment may be more frequent.
Aim: To determine the prevalence of renal disease in children with CF and to
identify associated risk factors.
Methods: A single-center retrospective study comprising 112 patients. Their
genetic, clinical and therapeutic characteristics were recorded. The estimated
glomerular ﬁltration rate (GFR) was determined using both the Schwartz and UV/P
formulae. Microalbuminuria and lithiasic risk factors were also analyzed. The X2
and Student-t tests, and the Spearman correlation coefﬁcient were used.
Results: The GFR (Schwartz) was (mean [IQR] ml/min/1.73 m2) 123 [87–
140], 161 [131–184] and 155 [134–184] in children aged 1, 6 and 15 years,
respectively. The correlation between Schwartz and UV/P GFR was poor (r = 0.12).
The cumulative dose of aminoglycosides was not correlated to GFR (Schwartz)
(r = 0.18). Microalbuminuria was present in 22/38 (58%) patients. Hyperoxaluria
was observed in 58/83 (70%) patients and was associated with a genotype of
severe phenotypic expression (p = 0.004), pancreas insufﬁciency (p = 0.007) and
liver disease (p = 0.02). Hypercalciuria (associated with liver disease (p = 0.05)),
hyperuricuria and hypocitraturia were identiﬁed in 16/87 (18%), 15/83 (18%) and
57/76 (75%) patients respectively.
Conclusion: Renal manifestations of CF are variable. There appears to be low
levels of renal impairment in children with CF, irrespective of nephrotoxic antibiotic
administration. However, 1) the risk of oxalocalcic urolithiasis is enhanced, and 2)
GFR may be underestimated by the Schwartz formula. Further studies using renal
EDTA-clearance are warranted.
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Introduction: CFTR is expressed in all nephron segments but in CF patients there
is no well established renal phenotype and no major primary renal dysfunction.
Objective: To evaluate proteinuria in our CF population and its correlation with
genotype. Secondary objectives were to assess correlation of proteinuria with CF
related diabetes and disease severity.
Methods: Prospective analysis of 22 CF patients that were evaluated for 24 hour
protein excretion within a 6-month period. Patients were divided into two groups: A
(proteinuria <150mg/day) and B (proteinuria 150mg/day). Genotype data were
obtained from patient ﬁles and the two main mutations, DF508 and R334W, were
considered. Due to the existence of genotype DF508 /R334W two categories were
created to enable statistical analysis so that in category 1 this genotype was ﬁled as
“DF508” and in category 2 as “R334W”. CF related diabetes data were obtained
from patient ﬁles and disease severity was assessed by acute exacerbations in the
last semester and FEV1, measured during the study period.
Results: In group A all patients (100%) were DF508 when considering category
1 and 86.7% for category 2. In group B 60% of patients were R334W when
considering category 1 and 80% for category 2. Therefore, mutation DF508 tended
to be associated to normal values of proteinuria and mutation R334W tended to be
associated with higher proteinuria values (p = 0.009 for category 1 group analysis
and p = 0.014 for category 2 group analysis).
No signiﬁcant relationship was found between the different groups and the other
variables.
Conclusions: Results suggest a possible mutation association eventually according
to the mechanism by which they disrupt CFTR function and renal phenotype.
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Background: Relatively little is known about disease-speciﬁc knowledge in adults
with CF. We report the development of the CFKQ, a questionnaire designed to
assess CF disease-speciﬁc knowledge. We present initial results of a study using
the CFKQ in a UK adult CF centre.
Methods: The CFKQ consists of 13 subject headings, each consisting of 5 multiple
choice questions with answers ‘True’, ‘False’ or ‘Don’t know’. It was designed to be
applicable to all CF adults, and includes questions we consider ‘core knowledge’.
We asked 2 additional questions ‘Where have you gained most knowledge about
issues related to CF up until now?’ and ‘How would you prefer to get information
about your condition in future?’. Patients were anonymized but asked to provide
their gender and age.
Results: We present results for 17 CF adults (9 male) – results for a larger
number of patients will be presented at ECFC 2009. Patients’ ages ranged from
16−21 to 50−60 years. The majority of patients (81%) reported having gained
most knowledge from the CF MDT and would like to gain future information
from the same source (88%). Median overall CFKQ score was 69.2%, with the
lowest scores in the subject headings: ‘Social issues’ (2/5), ‘Corticosteroid tablets’
(3/5) and ‘Absorption of vitamins’ (3/5). The question that was most commonly
answered incorrectly was: ‘Pancreatic enzymes (e.g. creon) mainly help to improve
the absorption of dietary protein’ (12/17 subjects incorrect).
Discussion: Initial data shows a wide range of disease-speciﬁc knowledge and
highlights gaps in the education of our patient population. We aim to validate
the CFKQ in a larger number of patients and plan to use the results to improve
educational resources available at Heartlands.
